Emerging evidence indicates that gut dysbiosis may promote amyloid-beta aggregation, neuroinflammation, oxidative stress, and insulin resistance in the pathogenesis of Alzheimer’s disease (AD; Liu et al., 2020). Here, INS is linked to early-onset autosomal dominant Alzheimer disease.